TORVANTA
Other · S&P 500 · data as of 2026-10-05

ADMA stock analysis: ADMA

ADMA (ADMA) is an S&P 500 company in Other. It grades strongest on profitability and weakest on momentum.

The model's view of ADMA · subscribers

Where ADMA ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with ADMA · updated 2026-10-05 · from prices and SEC filings

ADMA price performance

ADMA against the S&P 500, one year
-50%+0%S&P 500 +18%ADMA -31%2025-09-292026-10-05
Year to date-44.6%S&P 500 +14.5% · behind by 59.1 pts
1 year-31.0%S&P 500 +17.0% · behind by 48.1 pts
3 years+194.8%S&P 500 +89.3% · ahead by 105.5 pts
5 years+786.8%S&P 500 +91.3% · ahead by 695.5 pts

Total returns with dividends reinvested.

ADMA factor grades

Each grade compares ADMA with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

B-ValueP/E 14.4x (industry 20.1x)FCF yield 5.1% (industry 6.0%)
C+GrowthRevenue growth +8% (industry +8%)EPS growth -19% (industry +10%)
AProfitabilityOperating margin 43.8% (industry 9.6%)ROIC 37.4% (industry 10.1%)
C-Momentum12-month change -31%From 52-wk high -50%

ADMA in plain numbers

ADMA key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$2.3B
Revenue growth (y/y)+8%
Free-cash-flow yield5.1%
Dividend yieldn/a
Next earnings (expected)2026-11-04
Valuation measures
Market value$2.3B
Enterprise value$2.3B
P/E (trailing)14.4x
Forward P/E (Torvanta estimate)13.6x
PEG (Torvanta estimate)2.21
Price / sales4.4x
Price / book5.5x
EV / revenue4.5x
EV / EBITDA10.0x
Financial highlights
Revenue, last 12 months$512.3M
Net income, last 12 months$169.0M
EPS, last 12 months (GAAP)$0.70
Gross margin64.7%
Operating margin43.8%
Net margin33.0%
Return on equity41.9%
Return on invested capital37.4%
Cash$136.0M
Total debt$196.6M
Debt / equity0.48x
Free cash flow, last 12 months$116.5M
Interest cover25.4x
Current ratio6.97x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

ADMA earnings trends

Revenue vs earnings
$0$34.8M$69.6M$104.4M$139.2MSep 2024 Revenue: $119.8MDec 2024 Revenue: $117.5MMar 2025 Revenue: $114.8MJun 2025 Revenue: $122.0MSep 2025 Revenue: $134.2MDec 2025 Revenue: $139.2MMar 2026 Revenue: $114.5MJun 2026 Revenue: $124.4MSep 2024 Net income: $35.9MDec 2024 Net income: $111.9MMar 2025 Net income: $26.9MJun 2025 Net income: $34.2MSep 2025 Net income: $36.4MDec 2025 Net income: $49.4MMar 2026 Net income: $45.3MJun 2026 Net income: $37.8MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 30.0%Net margin: 95.2%Net margin: 23.4%Net margin: 28.1%Net margin: 27.1%Net margin: 35.5%Net margin: 39.6%Net margin: 30.4%0%48%95%■ Revenue ■ Net income ━ Net margin
Earnings per share$0.0$0.1$0.2$0.4$0.5Sep 2024 EPS (GAAP, diluted): $0.2Dec 2024 EPS (GAAP, diluted): $0.5Mar 2025 EPS (GAAP, diluted): $0.1Jun 2025 EPS (GAAP, diluted): $0.1Sep 2025 EPS (GAAP, diluted): $0.2Dec 2025 EPS (GAAP, diluted): $0.2Mar 2026 EPS (GAAP, diluted): $0.2Jun 2026 EPS (GAAP, diluted): $0.2Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 0% · Dec 2025 -57% · Mar 2026 +73% · Jun 2026 +14%

From the company's 10-Q and 10-K filings with the SEC.

ADMA financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$80.9M$154.1M$258.2M$426.5M$510.2M
Net income-$71.6M-$65.9M-$28.2M$197.7M$146.9M
EPS (GAAP)$-0.51$-0.34$-0.13$0.82$0.60
Free cash flow-$125.9M-$73.4M$4.0M$110.4M$27.8M

ADMA earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-05$0.16+14%+2%+13.3%
2026-05-06$0.19+73%-0%-18.4%
2026-02-25$0.20-57%+18%-2.5%
2026-01-12$0.20-57%+18%-1.4%
2025-11-05$0.150%+12%-3.4%
2025-08-06$0.14+8%+14%-12.3%

About ADMA

HeadquartersRamsey, NJ
Industry (SEC code)Biological Products, (No Diagnostic Substances)
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq
FormerlyR&R ACQUISITION VI, INC

From the company's SEC registration record.

Companies similar to ADMA

CompanyMarket valueP/ERevenue growthOperating margin12-month change
ADMA ADMA$2.3B14.4x+8%43.8%-31%
ANDE ANDE$2.3Bn/a-5%n/a+64%compare
APAM APAM$2.3B8.3x+10%33.0%-14%compare
MBIN MBIN$2.3B10.0xn/an/a+56%compare
LTC LTC$2.3B15.2x+60%62.6%+25%
BKE BKE$2.2B10.0x+6%20.8%-18%
RAMP RAMP$2.3B15.6x+9%11.6%+38%

All Other stock ratings

Frequently asked questions

Is ADMA stock a buy?

Torvanta does not tell individuals what to buy. Its grades for ADMA are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is ADMA's P/E ratio?

ADMA trades at about 14.4 times its last 12 months of GAAP earnings reported to the SEC, and about 13.6 times Torvanta's own estimate of the next 12 months.

When does ADMA report earnings next?

Based on its filing history, Torvanta expects ADMA to report around 2026-11-04.

How has ADMA performed against the S&P 500?

Over the past year ADMA returned -31.0%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer